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This  study  assesses  the  anti-arthritic  effect  of  the  afﬁnin-enriched  (spilanthol,  main  alkamide)  hexane
extract  from  the  roots  of  Heliopsis  longipes  (A. Gray) S.F.  Blake,  Asteraceae,  on a Freund  adjuvant-induced
arthritis  model  in rodents.  The  extract  was orally  administered  at a dose  of  2,  6.6,  or 20 mg/kg;  a signiﬁcant
edema-inhibitory  activity  in  the  acute  and chronic  phases  was  observed  with  a dose  of 2 and  20  mg/kg,eywords:
eliopsis longipes
fﬁnin
nti-arthritic
omplete Freund adjuvant
respectively.  The  extract  showed  higher  anti-inﬂammatory  and  anti-arthritic  effects  than the  reference
drug  phenylbutazone  (80  mg/kg).  Moreover,  the extract  prevented  the  occurrence  of secondary  lesions
associated  to  this  pharmacological  model.
©  2016  Sociedade  Brasileira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).pilanthol
ntroduction
Rheumatoid arthritis (RA) is an idiopathic auto-immune dis-
ase, characterized by symmetrical synovitis in large and small
oints that may  lead to progressive articular damage and disability
Mendoza-Vázquez et al., 2013). Analgesic and anti-inﬂammatory
rugs, including steroids, are used to suppress the symptoms. New
herapies, like those targeting the tumor necrosis factor alpha
inﬂiximab) or the anti-CD20 therapy (rituximab), which inhibit
he underlying immune process, have been proposed. However, all
hese drugs have several undesired effects. Recent research aims to
iscover long-acting anti-inﬂammatory drugs with minimal side
ffects (Ekambaram et al., 2010). A number of animal models are
sed to evaluate potentially useful compounds against RA, and the
hoice of a particular model depends on the immunological prop-
rties being observed in the model and their relation with the
uman disease. Among the available models is collagen-inducedPlease cite this article in press as: Escobedo-Martínez, C., et al. Heliopsi
induced model in rodents. Revista Brasileira de Farmacognosia (2016)
r adjuvant-induced (e.g., Freund’s adjuvant) arthritis in rodents,
pontaneous arthritis induced by TNF- or genetic models, like the
ransgenic animal model. While no RA model can be considered
∗ Corresponding author.
E-mail: c.escobedo@ugto.mx (C. Escobedo-Martínez).
http://dx.doi.org/10.1016/j.bjp.2016.09.003
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Edit
reativecommons.org/licenses/by-nc-nd/4.0/).ideal, Freund’s adjuvant-induced rat arthritis shares several traits
with human arthritis, and its sensitivity to evaluate anti-arthritic
agents was  the basis for its choice as the model to assess the activ-
ity of the Heliopsis longipes (A. Gray) S.F. Blake, Asteraceae, hexane
extract (Ekambaram et al., 2010; Tanushree and Saikat, 2013).
RA prevalence in developed countries is 0.5–2%, with an annual
incidence of 12–1200 per 100,000 inhabitants. The female:male
ratio is 2–3:1, and the peak age range of onset is 30–55 years
old, but it could occur at any age. In Mexico, RA affects 1.6% of
general population, being the main reason for consultation at the
Rheumatology Service (Mendoza-Vázquez et al., 2013; Guía de
Práctica Clínica, Diagnóstico y Tratamiento de Artritis Reumatoide
del Adulto, México: Secretaría de Salud, 2009).
H. longipes is a perennial herb, endemic in a region comprising
parts of Sierra de Alvarez and Sierra Gorda, near the triple border of
San Luis Potosi, Guanajuato and Queretaro, in Central Mexico. The
common names for this plant are chilcuague, pelitre, golden root,
and Aztec root (Cilia-López et al., 2008). The paralyzing and toxic
action against ﬂies and other insects of H. longipes root extracts
was discovered as similar as that of pyrethrins during World Wars longipes: anti-arthritic activity evaluated in a Freund’s adjuvant-
, http://dx.doi.org/10.1016/j.bjp.2016.09.003
II (Acree et al., 1945).
Fortunately, chilcuague did not become extinct after the expor-
tation boom, even though its wild population was  severely reduced.
To date, land plots solely dedicated to the cultivation of this species,
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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ural and Exact Science Vivarium at Universidad de Guanajuato,
were used. Animals were housed in groups of six, under con-ARTICLEJP-317; No. of Pages 6
 C. Escobedo-Martínez et al. / Revista Bra
isseminated either by seed or by cutting, can be found between
uanajuato and Queretaro; the root is fully developed after 2–3
ears (García-Chávez et al., 2004). It is the most economically
mportant species in its genus; its root is used in the region as
 cooking condiment, and it is added to alcoholic beverages to
mprove taste. In traditional medicine, chilcuague root is used to
reat respiratory diseases, as an anesthetic to treat tooth and mus-
ular aches, to treat buccal lesions, and as an anti-parasitic (Cilia
ópez, 2007). Several alkamides have been isolated from H. longipes,
ut afﬁnin, also known as spilanthol ((2E,6Z,8E)-N-isobutyl-2,6,8-
ecatrienamide), was identiﬁed as the main alkamide in the plant
Molina-Torres et al., 1996; García-Chávez et al., 2004; Hernández
t al., 2009). The oily substance causes intense lip numbness and
ingling within a few minutes after placed in the mouth, and it
lso stimulates salivation (Correa et al., 1971). H. longipes is also
eported to produce analgesia and anti-inﬂammation in human
ental and oral pathologies (Colvard et al., 2006). Additionally, it
as been reported that H. longipes dichloromethane extract showed
nalgesic activity, as demonstrated in vitro by releasing of gamma-
minobutyric acid (GABA) in mouse brain slices; the increase in
ABA release in a region of cerebral cortex leads to sustained
nalgesia, favoring a descendent inhibition of nociceptive spinal
eurons (Ríos et al., 2007).
With regard to anti-inﬂammatory activity, Hernández et al.
2009) evaluated H. longipes ethanolic extract and puriﬁed afﬁnin
n mouse ear edema induced by either arachidonic acid (AA)
r phorbol 12-myristate 13-acetate (PMA), demonstrating a sig-
iﬁcant anti-inﬂammatory effect. DE50 values of 0.8 mg/ear and
.2 mg/ear were obtained, respectively, in the AA-induced edema
odel; nimesulide (1 mg/ear) was used as reference drug. In
he PMA-induced edema model, the ethanolic extract and afﬁnin
howed a dose-dependent anti-inﬂammatory effect with DE50 val-
es of 2 mg/ear and 1.3 mg/ear, respectively, using indometacin
3 mg/ear) as reference drug.
On the other hand, Cilia-López et al. (2010) evaluated the anal-
esic activity of H. longipes ethanolic extract and afﬁnin and their
ffect on the central nervous system on a mouse model; both afﬁnin
1 mg/kg) and H. longipes root ethanolic extract (10 mg/kg) showed
n analgesic action similar to ketorolac (6 mg/kg), as assessed by
ain induction with acetic acid and thermal stimulation (hot plate);
lso, H. longipes extract and afﬁnin showed a stimulant effect on
he central nervous system comparable to caffeine, as measured by
he Irwin test. Carin˜o-Cortés et al. (2010) evaluated the cytotoxic
otential of H. longipes ethanolic extract by recording the vari-
bility in the count of micronucleated polychromatic erythrocytes
nduced by the extract and the ratio of polychromatic erythro-
ytes with respect to normochromatic erythrocytes; no signiﬁcant
ytotoxic effect was observed. However, brain histopathological
tudies showed necrotic changes in the gray matter, described as
olioencephalomalacia and neurophagy, at a dose of 1000 mg/kg
f ethanolic extract. No damage or histopathological change
as observed in other organs (liver, heart, kidney, spleen, and
ung).
Among the recent studies on H. longipes is the assessment of
thanolic extract and afﬁnin as potential anti-mutagenic and anti-
arcinogenic agents. The anti-mutagenic properties of afﬁnin were
valuated by adding it to several mutagens, either with or without
9 metabolic activation, in Salmonella typhimurium (TA98, TA100,
nd TA102 strains) cultures. Afﬁnin signiﬁcantly decreased the
oint mutations induced by 2-aminoanthracene (2AA) (40%) and
ecreased the DNA oxidative damage induced by norﬂoxacin (NOR)
37–50%). Additionally, it showed antioxidant properties capable
f reducing the rate of 2AA- and NOR-induced mutation in S.
yphimurium TA98 and TA102, respectively, which could be rele-Please cite this article in press as: Escobedo-Martínez, C., et al. Heliopsi
induced model in rodents. Revista Brasileira de Farmacognosia (2016)
ant to treat some pain symptoms related to anti-radical activity
Arriga-Alba et al., 2013). PRESS
 de Farmacognosia xxx (2016) xxx–xxx
Materials and methods
Plant material
Heliopsis longipes (A. Gray). S.F. Blake, Asteraceae, roots were col-
lected on February 16, 2014, 2:14:59 pm,  within the boundaries of
a land plot in Beltran community (N 21◦16.427′, W 100◦0.2672′) at
1780 m above sea level, Xichu municipality, in Guanajuato, Mexico.
After proper identiﬁcation, ﬁve plant specimens were deposited in
the Isidro Palacios herbarium (SLPM), at the Universidad Autónoma
de San Luis (No. 048150).
Extraction
Dry, ground H. longipes roots (1285 g) were macerated for three
consecutive times: First component extraction was performed
with 2.5 l of hexane for 2 h; then, the recovered extract solu-
tion (1750 ml)  was evaporated, yielding a dark yellow, viscous oil
(26.386 g, labeled as Hl-A). A second maceration was performed on
the same plant material after the ﬁrst extraction, adding 1.250 l of
hexane and left for 24 h; extract solution (1 l) was recovered, and
after evaporation it yielded 12.29 g of viscous oil, labeled as Hl-B. A
third and last maceration was  performed as described above, using
1.5 l of hexane for 4 h, recovering an extract solution (900 ml)  and
yielding 3.469 g of viscous oil, labeled as Hl-C. Each maceration was
monitored by thin-layer chromatography. The Hl-A sample yielded
26.386 g of afﬁnin (1), with a 95% purity.
HPLC and NMR analysis
High performance liquid chromatography (HPLC) analysis of the
Hl-A sample was performed in a Waters 1525 Binary HPLC pump
equipment, controlled by Breeze software. A 15 cm × 4.6 mm,  C18
Kromasil 100-5 column was  used, coupled to a diode array detector
(maximum absorbance was  set to 230 nm). A water-acetonitrile
gradient from 60:40 to 30:70 in 25 min  was used for elution, at a
ﬂow rate of 1 ml/min (Fig. 1).
Magnetic nuclear resonance (NMR) measurements for the Hl-
A sample were acquired in an Agilent 600 MHz, DD2, Oneprobe
equipment for 1H y 13C in CDCl3 solution, using tetramethylsilane
as internal standard (Tables 1 and 2). Chemical shift readings were
compared with those reported in the literature (Correa et al., 1971).
Pharmacological assay
Animals
All experiments were performed in accordance with eth-
ical standards for experimental pain research in animals
(Zimmermann, 1983) and the Mexican Ofﬁcial Standard for ani-
mal  care and handling (NOM-062-ZOO-1999). The experimental
protocol (CIBIUG-P01-2016) was  approved and overseen by the
Institutional Ethics Committee for Care and Use  of Laboratory
Animals of the Universidad de Guanajuato. Inbred Wistar rats
(250–300 g) and Balb/c mice (20–25 g), obtained from the Nat-s longipes: anti-arthritic activity evaluated in a Freund’s adjuvant-
, http://dx.doi.org/10.1016/j.bjp.2016.09.003
trolled temperature (23 ± 2 ◦C) and humidity (55 ± 10%), with
a 12-h light/darkness cycle, and were familiarized with the
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Fig. 1. Chromatogram of the Hl-A sample afﬁnin (1), injected at a c
Table 1
1H NMR  spectral data of Hl-A component (afﬁnin) (600 MHz).a
Protona Chemical
shift
Multiplicity Area Coupling
constant (Hz)
CH3-3′ and CH3-4′ 0.92 d 6 J = 6.8
CH3-10 1.77 d 3 J = 7.2
H-2′ 1.80 m 1 J = 6.0
CH2-4 and CH2-5 2.24, 2.32 dc 4 J = 18.0, 6.0
CH2-1′ 3.13 t 2 J = 6.9
H-6 5.26 dt 1 J = 12.0, 6.0
H-9 5.69 dc 1 J = 13.7, 6.7
H-2 5.86 d 1 J = 15.0
H-7 5.96 t 1 J = 11.0
H-8 6.28 dd broad signal 1 J = 18.0, 12.0
H-3 6.82 dt 1 J = 15.2, 6.7
N-H 6.0 Broad signal 1
a Data recorded in CDCl3. Chemical shifts (ı) are expressed in ppm with respect to
tetramethylsilane (TMS). Coupling patterns are labeled as: d, doublet; dd, doublet of
doublets; dt, doublet of triplets; t, triplet; dc, doublet of quartets; m, multiplet. All
assignments were based on the following experiments: 1H-1D, 13C-1D, COSY (corre-
lation spectroscopy), HSQC (heteronuclear single quantum coherence; coupling of
1H 13C to a bond), and HMBC (heteronuclear multiple bond correlation; coupling
of 1H 13C to 2 and 3 bonds).
Table 2
13C NMR  spectral data of Hl-A component (afﬁnin) (125.7 MHz).a
Carbona Chemical shift
C-10 18.30
C-3′ and C-4′ 20.16
C-5 26.42
C-2′ 28.58
C-4 32.12
C-1′ 46.91
C-6 124.26
C-8 126.70
C-7 127.63
C-2 129.43
C-3 129.89
C-9 143.36
C-1 166.17
a
t
1
e
a
i
A
(
1
o
t
mData recorded in CDCl3. Chemical shifts (ı) are expressed in ppm with respect to
etramethylsilane (TMS). All assignments were based on the following experiments:
H-1D, 13C-1D, COSY, HSQC, and HMBC.
nvironment one week before the experiments. Animals were
llowed food and water ad libitum. Immediately after the exper-
ments, all animals were sacriﬁced in a CO2 chamber.
cute toxicity assays
The DL50 value per os was determined as reported by Lorke
1983). Mice were treated with Hl-A doses of 10, 100, orPlease cite this article in press as: Escobedo-Martínez, C., et al. Heliopsi
induced model in rodents. Revista Brasileira de Farmacognosia (2016)
000 mg/kg. Animals were maintained under close observation
ver a 14-day period. The weight of the animals was  monitored
hroughout the experiments, and the death or survival of the ani-
als was registered.tes
oncentration of 1 mg/ml  and read at a wavelength of 230 nm.
Anti-inﬂammatory activity
Arthritis syndrome was  induced by a plantar intradermic injec-
tion (through a 20-gauge needle) in the right hind paw of 0.05 ml  of
complete Freund’s adjuvant (Sigma Aldrich). This method, reported
by Newbould (1963), has been widely used to detect potential anti-
inﬂammatory drugs with anti-arthritic activity. Among the several
adjuvant types available, the most commonly used in experimen-
tal animals is Freund’s adjuvant; two  varieties of Freund’s adjuvant
are used: Incomplete Freund Adjuvant (IFA) and Complete Freund
Adjuvant (CFA). IFA consists in a mixture of surfactant and mineral
oil, usually Arlacel and Drakeol; CFA also contains killed mycobacte-
ria, usually Mycobacterium bovis BCG at a concentration of 1 mg/ml
or less (Rojas-Espinosa, 2006).
Edema degree was evaluated by the volume displacement
method, using a PAN LAB digital plethysmometer. Volume displace-
ment was  recorded 24 h before and 8, 24, 48, 72, and 96 h after
CFA injection. To complete the assessment of activity on arthri-
tis induction, volume variations in the hind paw were recorded
up to 25 days after injection. Phenylbutazone (reference drug,
Sigma Aldrich, 80 mg/kg) or the Hl-A sample (in a dose of 2, 6.6,
or 20 mg/kg) were administered p.o.  24 h before CFA injection and
daily for 14 days after. The severity and progression of secondary
lesions in test animals were also compared.
The percentage of edema inhibition was  calculated for all ani-
mals in each treatment group with respect to a vehicle-treated
control group. Differences between control and treatment groups
were analyzed by Tukey’s test. A p-value lower than 0.05 was
regarded as statistically signiﬁcant.
Results
Acute toxicity assays
The DL50 value p.o.  for the Hl-A sample was 775 mg/kg.
Anti-inﬂammatory activity
Progression of Freund’s adjuvant-induced arthritis in rats
CFA injection in the right hind paw caused inﬂammation, which
peaked within the ﬁrst 8 h. Then, inﬂammation slowly decreased
until day 6 post-injection, had a slight increase after day 7, and
showed a sustained increase until the end of the experiment. At
day 16 post-CFA-injection and until the end of the period of study,
inﬂamed lesions (secondary lesions) in the left hind paw were
detected, as well as deformed front paws and increasing thickness
in ears and tail (Fig. 2).s longipes: anti-arthritic activity evaluated in a Freund’s adjuvant-
, http://dx.doi.org/10.1016/j.bjp.2016.09.003
Dosing
Each tested concentration of the Hl-A sample and of phenylbu-
tazone was administered daily for 15 days. The ﬁrst dose was
ARTICLE IN PRESSG ModelBJP-317; No. of Pages 6
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Fig. 2. Secondary lesions observed on the day 22 after plantar injection of complete Freund’s adjuvant in a rat from the control, untreated group.
Table 3
Effect of Hl-A on Freund’s adjuvant-induced edema in rats.
Time (h) Sample Dose (mg/kg) % Inhibition ± SEM
8 Phenylbutazone 80 46.5 ± 6.8*
8 Hl-A 2 18.9 ± 7.5
8  Hl-A 6.6 14.5 ± 8.1
8  Hl-A 20 17.5 ± 8.6
24  Phenylbutazone 80 47.8 ± 5.6*
24  Hl-A 2 42.3 ± 4.2*
24  Hl-A 6.6 29.7 ± 11.3
a
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Fig. 3. Acute effect of administration (p.o.) of phenylbutazone (80 mg/kg) or Heliop-24  Hl-A 20 31.7 ± 10.3
* Data were analized by ANOVA followed by Tuke’s test. p < 0.05.
dministered 1 day before CFA injection in the right hind paw pad
Newbould, 1963). Frequent measurements in the hind paws with
 plethysmometer showed that the treatment with phenylbuta-
one and with the tested Hl-A concentrations (2, 6.6, or 20 mg/kg)
nhibited inﬂammation in the hind paw during the dosing period.
s shown in Fig. 4, prophylactic treatment with the reference drug
phenylbutazone, 80 mg/kg) signiﬁcantly inhibited the inﬂamma-
ory effect of CFA injection 8 h after the stimulus, during the
cute inﬂammation phase. This was observed again 24 h after
njection; additionally, administration p.o. of Hl-A at a dose of
 mg/kg inhibited the progression of acute-phase edema by 42.3%
F4,20 = 4.7) (Table 3, Fig. 3).
During inﬂammation chronic phase, signiﬁcant values of inhi-
ition percentage after administration p.o.  of Hl-A at a dose of
0 mg/kg were observed only on days 19, 20, 23, and 25 after CFA
njection, with inhibition percentages of 31.1 (F4,20 = 5.012), 36.8
F4,20 = 3.17), 34.2 (F4,20 = 3.56), and 31.3 (F4,20 = 4.30), respectively
Table 4 and Fig. 4). On the other hand, Hl-A administration at the
ame dose showed a higher inhibition percentage than phenylbu-
azone in all chronic-phase days. Secondary lesions did not occur
uring the treatment period at all Hl-A doses (Fig. 5), and rats from
l-A-treated groups showed a better joint mobility.
No signiﬁcant difference was observed in corporal weight
etween phenylbutazone-treated nor Hl-A-treated rat groups at
ny dose with respect to the control, untreated group.
iscussion
A number of animal models have been proposed to evaluate
nti-inﬂammatory activity, like the use of substances such as for-
alin of dextran, which cause acute inﬂammation when injected
n rat hind paws. However, these models require administering
igh doses of anti-inﬂammatory drugs like phenylbutazone, oftenPlease cite this article in press as: Escobedo-Martínez, C., et al. Heliopsi
induced model in rodents. Revista Brasileira de Farmacognosia (2016)
ear toxic values, to signiﬁcantly inhibit inﬂammation (Domenjoz,
960). Another method is the subcutaneous implant of cotton pel-
ets, a model that is more sensitive to steroid anti-inﬂammatory
rugs but is relatively insensitive to non-steroid anti-inﬂammatorysis longipes Hl-A sample (2, 6.6, and 20 mg/kg) on Freund’s adjuvant-induced
inﬂammation in the hind paw of the rodent model (rat). Each bar shows the mean of
5  lectures ± SEM. Data were analyzed by ANOVA followed by Tukey’s test. p < 0.05.
drugs like phenylbutazone (Winder et al., 1962). The method used
in this study is based on a syndrome more similar to rheumatoid
arthritis, which is capable of detecting anti-inﬂammatory activity
in a wide range of drug types useful to treat rheumatoid arthritis in
humans (Pearson et al., 1961; Pearson and Wood, 1963).
Phenylbutazone, previously used in other models, was  a suitable
reference drug to inhibit inﬂammation caused by CFA injection in
rat hind paw; no weight-loss was observed as reported with other
drugs (Newbould, 1963). In our study, phenylbutazone inhibited
CFA-induced inﬂammation by 46.5% 8 h after injection (Table 3),
a very similar result to that reported by Abad et al. (1996), who
recorded an inhibition rate of 40% 24 h after stimulus, increasing
to over 70% at 72 h and decreasing again to 40% at 96 h, remaining
constant until the day 15. In our study, the control drug was  dis-
continued on the chronic phase, but inhibition rate remained in a
range of 23–27%, indicating a long-term effect. On the other hand,
an inhibition range of 27.2–36.8% was observed in the Hl-A-treateds longipes: anti-arthritic activity evaluated in a Freund’s adjuvant-
, http://dx.doi.org/10.1016/j.bjp.2016.09.003
group (20 mg/kg), higher than that of the phenylbutazone-treated
animals.
The process underlying the occurrence of secondary lesions
in the model herein used is non-infectious, and it is suggested
Please cite this article in press as: Escobedo-Martínez, C., et al. Heliopsi
induced model in rodents. Revista Brasileira de Farmacognosia (2016)
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Fig. 4. Effect administration (p.o.) of phenylbutazone (80 mg/kg) or Heliopsis
longipes Hl-A sample (2, 6.6, and 20 mg/kg) on the long-term, Freund’s adjuvant-
induced inﬂammation phase in the hind paw of the rodent model (rat). Each point
in  time-course shows the mean of ﬁve lectures ± SEM. Data were analyzed by ANOVA
followed by Tukey’s test. p < 0.05.
Table 4
Effect of Hl-A on Freund’s adjuvant-induced edema in rats.
Time (days) Sample Dose (mg/kg) % Inhibition ± SEM
16 Phenylbutazone 80 23.8 ± 3.0
16  Hl-A 2 25.8 ± 3.0
16  Hl-A 6.6 17.9 ± 6.8
16  Hl-A 20 29.6 ± 5.9
17  Phenylbutazone 80 20.5 ± 0.8
17  Hl-A 2 15.8 ± 2.7
17  Hl-A 6.6 16.8 ± 4.8
17  Hl-A 20 25.2 ± 6.2
18  Phenylbutazone 80 22.4 ± 3.4
18  Hl-A 2 26.0 ± 2.9
18  Hl-A 6.6 13.5 ± 3.5
18  Hl-A 20 30.3 ± 5.3
19  Phenylbutazone 80 20.6 ± 3.2*
19 Hl-A 2 31.9 ± 4.0*
19 Hl-A 6.6 17.39 ± 2.5
19  Hl-A 20 31.1 ± 6.3*
20 Phenylbutazone 80 25.8 ± 3.2
20  Hl-A 2 27.8 ± 5.5
20  Hl-A 6.6 29.9 ± 3.9
20  Hl-A 20 36.8 ± 7.2*
21 Phenylbutazone 80 23.8 ± 4.4
21  Hl-A 2 20.5 ± 2.1
21  Hl-A 6.6 21.0 ± 5.1
21  Hl-A 20 30.9 ± 2.7
22  Phenylbutazone 80 27.41 ± 4.5
22  Hl-A 2 8.6 ± 3.1
22  Hl-A 6.6 19.0 ± 3.4
22  Hl-A 20 27.2 ± 5.4
23  Phenylbutazone 80 27.9 ± 4.6
23  Hl-A 2 21.5 ± 3.4
23  Hl-A 6.6 26.9 ± 3.6
23  Hl-A 20 34.2 ± 4.1*
24 Phenylbutazone 80 25.5 ± 6.1
24  Hl-A 2 19.2 ± 4.9
24  Hl-A 6.6 25.3 ± 4.9
24  Hl-A 20 30.1 ± 3.7
25  Phenylbutazone 80 26.0 ± 5.7*
25 Hl-A 2 18.3 ± 3.8
25  Hl-A 6.6 25.0 ± 3.8
25  Hl-A 20 31.3 ± 3.2*
* Data were analized by ANOVA followed by Tuke’s test. p < 0.05.Fig. 5. Status of the right hind paw of a subject rat on day 22 after prophylactic
treatment with Hl-A (p.o.) at a dose of 20 mg/kg.
to be result of a generalized immune response to the compo-
nents of tubercle bacilli, disseminated after local administration
(Warsman and Sharp, 1960). Neither phenylbutazone-treated nor
Hl-A-treated rats at any dose (2, 6.6, or 20 mg/kg) showed sec-
ondary lesions, in contrast with control, untreated animals (Fig. 5);
this indicates that treatments modify the immune response.
On the other hand, the highest extract dose (20 mg/kg) was set to
much lower value than the DL50 value herein reported (775 mg/kg,
p.o.), which allows us to regard it as a low-toxicity substance
(Lorke, 1983). Extract accumulation due to a daily administration
for 15 days failed to cause any toxicity sign in the period of study.
Therefore, herein we provide information supporting the potential
anti-inﬂammatory usefulness of H. longipes hexane extract (Hl-
A), which has afﬁnin as its main constituent as shown by HPLC
and NMR  analysis. The potential usefulness as anti-inﬂammatory
agent of the extract at a low dose (2 mg/kg) was demonstrated
in the acute-phase inﬂammation of the model, while its anti-
inﬂammatory and anti-arthritic activity at higher but secure doses
(20 mg/kg) was  demonstrated in the chronic-phase inﬂammation
of the model, with no occurrence of secondary lesions.
Conclusions
The hexane extract of H. longipes, of which afﬁnin is the main
constituent, has potential usefulness as an anti-arthritic agent. This
study contributes to provide information supporting the traditional
use of this plant species. It is noteworthy that the available infor-
mation about this species would sufﬁce to create a monograph and
suggest the production of a phytopharmaceutical, which would
help encouraging a standardized, high-quality cultivation of this
plant species and improve the economy of peasants in Sierra Gorda,
Mexico.
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